Inventor · disambiguated record
Clet Niyikiza
Also filed as: NIYIKIZA CLET
39 granted patents·50 pending applications·305 citations·filing 2001–2025
97Inventor score
Files withL E A F HOLDINGS GROUP LLC64IPSEN BIOPHARM LTD9MERRIMACK PHARMACEUTICALS INC8LILLY CO ELI3BULLER RICHARD2
Top patents by PatentIndex Score
89 records- 0199US11701432B2Polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2022·Granted Jul 18, 2023·17 cites·32 claims
- 0299US11344628B2Alpha polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2017·Granted May 31, 2022·32 cites·36 claims
- 0398US12178883B2Alpha and gamma-D polyglutamated pemetrexed antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2021·Granted Dec 31, 2024·2 cites·30 claims
- 0498US11534498B2Polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2017·Granted Dec 27, 2022·29 cites·27 claims
- 0597US12178882B2Alpha polyglutamated pemetrexed and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2021·Granted Dec 31, 2024·2 cites·19 claims
- 0697US12048766B2Gamma polyglutamated tetrahydrofolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Jul 30, 2024·14 cites·43 claims
- 0797US11779584B2Alpha polyglutamated pemetrexed and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Oct 10, 2023·13 cites·38 claims
- 0897US11771700B2Gamma polyglutamated lometrexol and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Oct 3, 2023·11 cites·46 claims
- 0997US11730738B2Alpha polyglutamated pralatrexate and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Aug 22, 2023·10 cites·47 claims
- 1097US9717724B2Methods for treating pancreatic cancer using combination therapiesIPSEN BIOPHARM LTD·Filed 2016·Granted Aug 1, 2017·14 cites·24 claims
- 1196US12048767B2Gamma polyglutamated pralatrexate and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Jul 30, 2024·10 cites·23 claims
- 1296US10980795B2Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanIPSEN BIOPHARM LTD·Filed 2018·Granted Apr 20, 2021·8 cites·15 claims
- 1396US9492442B2Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2015·Granted Nov 15, 2016·19 cites·30 claims
- 1496US7772209B2Antifolate combination therapiesLILLY CO ELI·Filed 2007·Granted Aug 10, 2010·37 cites·22 claims
- 1595US9339497B2Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2015·Granted May 17, 2016·17 cites·27 claims
- 1694US9364473B2Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2015·Granted Jun 14, 2016·12 cites·29 claims
- 1793US11369597B2Methods for treating pancreatic cancer using combination therapiesIPSEN BIOPHARM LTD·Filed 2018·Granted Jun 28, 2022·4 cites·13 claims
- 1893US2025018055A1Alpha and gamma-d polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 1993US2025127920A1Gamma-d polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 2093US2025099608A1Polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 2192US12128046B2Alpha polyglutamated methotrexate and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Oct 29, 2024·4 cites·21 claims
- 2292US12076402B2Alpha polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Sep 3, 2024·6 cites·52 claims
- 2392US9452162B2Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2013·Granted Sep 27, 2016·12 cites·35 claims
- 2492US2024390514A1Polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 2589US2024226090A1Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal IrinotecanIPSEN BIOPHARM LTD·Filed 2024·Application pending·0 cites
- 2688US2024342162A1Methods For Treating Pancreatic Cancer Using Combination TherapiesIPSEN BIOPHARM LTD·Filed 2024·Application pending·0 cites
- 2787US2023381338A1Polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2023·Application pending·0 cites
- 2885US12213981B2Alpha polyglutamated pralatrexate and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2023·Granted Feb 4, 2025·0 cites·45 claims
- 2985US7053065B2Vitamin B12 and pemetrexed disodium combination therapiesLILLY CO ELI·Filed 2001·Granted May 30, 2006·31 cites·7 claims
- 3083US12201695B2Polyglutamated pemetrexed and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2021·Granted Jan 21, 2025·0 cites·26 claims
- 3183US2025152511A1Platinum complexes and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 3283US2025195686A1D glutamate polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2025·Application pending·0 cites
- 3382US12364691B2Methods for treating pancreatic cancer using combination therapiesIPSEN BIOPHARM LTD·Filed 2022·Granted Jul 22, 2025·0 cites·5 claims
- 3481US12433893B2Alpha polyglutamated pemetrexed and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2023·Granted Oct 7, 2025·0 cites·25 claims
- 3581US2025161455A1Alpha polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 3680US12458597B2Carotenoid compositions and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Nov 4, 2025·1 cites·39 claims
- 3780US12296022B2D glutamate polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2022·Granted May 13, 2025·0 cites·27 claims
- 3879US2025177304A1Targeted liposomal gemcitabine and methods thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 3978US2025213476A1Gamma polyglutamated raltitrexed and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 4077US2025082575A1Gamma polyglutamated pralatrexate and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 4177US2025066468A1Liposome encapsulated affinity drugL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 4277US2022096458A1Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal IrinotecanIPSEN BIOPHARM LTD·Filed 2021·Application pending·0 cites
- 4377US2025082639A1Alpha polyglutamated methotrexate and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 4476US2025198442A1Gamma polyglutamated pemetrexed and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2025·Application pending·0 cites
- 4575US12161757B2Platinum complexes and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2021·Granted Dec 10, 2024·0 cites·30 claims
- 4675US2024252498A1Gamma polyglutamated lometrexol and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2023·Application pending·0 cites
- 4773US12290518B2Gamma polyglutamated methotrexate and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted May 6, 2025·0 cites·23 claims
- 4871US12336994B2Alpha polyglutamated tetrahydrofolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Jun 24, 2025·0 cites·20 claims
- 4969US12246019B2Alpha polyglutamated lometrexol and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Mar 11, 2025·0 cites·20 claims
- 5069US12115256B2Targeted liposomal gemcitabine and methods thereofL E A F HOLDINGS GROUP LLC·Filed 2021·Granted Oct 15, 2024·0 cites·24 claims
Showing the top 50 of 89 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Clet Niyikiza files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →